Loading…

Short fully covered self‐expandable metal stent for treatment of proximal anastomotic benign biliary stricture after living‐donor liver transplantation

Objectives Non‐surgical methods have high success rates for treating benign biliary strictures (BBSs), but treatment of proximal strictures is difficult. Recent studies have reported that fully covered self‐expandable metal stents (FCSEMSs) are useful for treating refractory BBSs. We investigated th...

Full description

Saved in:
Bibliographic Details
Published in:Digestive endoscopy 2021-07, Vol.33 (5), p.840-848
Main Authors: Jang, Sung Ill, Chung, Tae Ryong, Cho, Jae Hee, Lee, Kwang‐Hun, Joo, Seung‐Moon, Choi, Jung Hye, Kim, Sae In, Lee, Dong Ki
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objectives Non‐surgical methods have high success rates for treating benign biliary strictures (BBSs), but treatment of proximal strictures is difficult. Recent studies have reported that fully covered self‐expandable metal stents (FCSEMSs) are useful for treating refractory BBSs. We investigated the efficacy of a short and removable FCSEMS with an anti‐migration design for treatment of proximal BBSs. Methods Fully covered self‐expandable metal stents were inserted endoscopically in patients with BBSs after living donor liver transplantation (LDLT). Each FCSEMS was initially maintained for 3 months and subsequently exchanged every 3 months until the stricture resolved. Adverse events and stricture recurrence after FCSEMS removal were assessed during follow‐up. Results A total of 63 patients with a median age of 57 years were enrolled in this study; 50 were male. The most common underlying disease was hepatocellular carcinoma and the previous operation was LDLT. The mean duration from surgery to diagnosis of stricture was 8.5 months, and the mean stent indwelling time was 4.2 months. The technical success and stricture resolution rate were 100%. The recurrence rate was 23.8% and the adverse event rate was 12.7%. All stents were removable, and asymptomatic stent migration was observed in four patients (6.4%). Conclusions The newly designed FCSEMS is effective in the treatment of proximal BBSs after LDLT.
ISSN:0915-5635
1443-1661
DOI:10.1111/den.13871